INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 52 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,713,000 | +5.5% | 4,563,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,518,000 | -4.1% | 4,563,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,669,000 | +6.8% | 4,563,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,434,000 | -5.9% | 4,563,000 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $3,651,000 | -16.9% | 4,563,000 | +4.7% | 0.01% | 0.0% |
| Q4 2019 | $4,394,000 | +32.9% | 4,358,000 | +13.3% | 0.01% | +25.0% |
| Q3 2019 | $3,307,000 | -13.1% | 3,845,000 | -9.9% | 0.00% | -20.0% |
| Q2 2019 | $3,805,000 | -18.7% | 4,267,000 | -9.8% | 0.01% | -16.7% |
| Q1 2019 | $4,680,000 | +60.7% | 4,729,000 | +49.6% | 0.01% | +50.0% |
| Q4 2018 | $2,912,000 | – | 3,161,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $56,098,000 | 1.12% |
| L & S Advisors Inc | 795,000 | $767,000 | 0.14% |
| OAKTREE CAPITAL MANAGEMENT LP | 9,964,000 | $9,690,000 | 0.11% |
| WEDBUSH SECURITIES INC | 13,000 | $1,251,000 | 0.07% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,163,000 | $3,076,000 | 0.06% |
| ZAZOVE ASSOCIATES LLC | 246,000 | $240,000 | 0.02% |
| Balboa Wealth Partners | 21,000 | $20 | 0.01% |
| Russell Investments Group, Ltd. | 1,910,000 | $1,875,000 | 0.00% |
| GAMCO INVESTORS, INC. ET AL | 250,000 | $244,000 | 0.00% |
| Regal Investment Advisors LLC | 20,000 | $19,000 | 0.00% |